Kraig Biocraft Laboratories, Inc. announced that senior management members will travel to Vietnam this week to oversee the launch of the spring production trials and lay the groundwork for the Company's planned commercial expansion. The launch of the BAM-1 production trial is the next critical benchmark in the Company's plan for commercial-scale production of recombinant spider silk. Management will closely monitor all aspects of the spring trials, which are seen as the probable blueprint for large-scale production of spider silk.

In addition to overseeing the spring production trials, senior management plans to lay the groundwork for further production growth, scouting and identifying down-market production partners, and finalizing agreements with private and governmental entities.